Sustainable discovery and development of antibiotics — is a non-profit approach the future?

New England Journal of Medicine

19 June 2019 - Shifting to a nonprofit-driven model for development of antibiotics could encourage discovery and development of truly needed drugs that improve patient outcomes and permit more effective control over the post-approval use of antibiotics to prolong their effectiveness.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder